Growth
Enhanced Packaging accelerates your molecule’s success by putting it in a class by itself.
Baxter’s portfolio of proprietary packaging solutions has helped some of the world’s leading pharma and biotechnology customers create unique advantages even in crowded drug classes – and build long-lasting market differentiation. Whether you’re trying to distinguish your molecule from similar products in the marketplace, or looking for a product extension for lifecycle management, Baxter can help maximize your product’s clinical acceptance while enhancing your molecule’s success.
Launch of Premix drives 47% incremental molecule growth
Creating an alternative delivery method can produce dramatic results. In the case of an antibiotic previously sold in vials, Baxter developed a proprietary, Ready-to-Use Premix formulation that was quickly adopted by customers. The new presentation resulted in 47% incremental molecule growth over 3 years – while reducing costly delays associated with vial reconstitution and foaming.
Information Resources
Search by:
- Product
- Solution
Search by keyword or key phrase:
You will need one of the following free applications to view files on this page:
Adobe Reader to view
PDF ( ) files.
